ID   CYFP2_HUMAN             Reviewed;        1278 AA.
AC   Q96F07; A6NLT2; D3DQJ3; Q53EN5; Q9NTK4; Q9ULQ2; Q9UN29;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 2.
DT   28-JUN-2023, entry version 164.
DE   RecName: Full=Cytoplasmic FMR1-interacting protein 2;
DE   AltName: Full=p53-inducible protein 121;
GN   Name=CYFIP2 {ECO:0000312|EMBL:AAH11762.1};
GN   Synonyms=KIAA1168, PIR121 {ECO:0000312|EMBL:AAD45723.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAD45723.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10449408; DOI=10.1093/emboj/18.16.4424;
RA   Saller E., Tom E., Brunori M., Otter M., Estreicher A., Mack D.H., Iggo R.;
RT   "Increased apoptosis induction by 121F mutant p53.";
RL   EMBO J. 18:4424-4437(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND RNA EDITING OF
RP   POSITION 320.
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis from
RT   size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:CAB66484.1}
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND RNA EDITING OF
RP   POSITION 320.
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:CAB66484.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAD97324.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:CAB66484.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAH11762.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lymph {ECO:0000312|EMBL:AAH11762.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH RAC1, AND TISSUE SPECIFICITY.
RX   PubMed=15048733; DOI=10.1002/eji.200324726;
RA   Mayne M., Moffatt T., Kong H., McLaren P.J., Fowke K.R., Becker K.G.,
RA   Namaka M., Schenck A., Bardoni B., Bernstein C.N., Melanson M.;
RT   "CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients
RT   and is involved in T cell adhesion.";
RL   Eur. J. Immunol. 34:1217-1227(2004).
RN   [10] {ECO:0000305}
RP   RNA EDITING OF POSITION 320.
RX   PubMed=15731336; DOI=10.1093/nar/gki239;
RA   Levanon E.Y., Hallegger M., Kinar Y., Shemesh R., Djinovic-Carugo K.,
RA   Rechavi G., Jantsch M.F., Eisenberg E.;
RT   "Evolutionarily conserved human targets of adenosine to inosine RNA
RT   editing.";
RL   Nucleic Acids Res. 33:1162-1168(2005).
RN   [11] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=17245118; DOI=10.4161/cc.6.1.3665;
RA   Jackson R.S. II, Cho Y.-J., Stein S., Liang P.;
RT   "CYFIP2, a direct p53 target, is leptomycin-B sensitive.";
RL   Cell Cycle 6:95-103(2007).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1062, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   INTERACTION WITH FMR1.
RX   PubMed=24658146; DOI=10.1371/journal.pone.0091465;
RA   Taha M.S., Nouri K., Milroy L.G., Moll J.M., Herrmann C., Brunsveld L.,
RA   Piekorz R.P., Ahmadian M.R.;
RT   "Subcellular fractionation and localization studies reveal a direct
RT   interaction of the fragile X mental retardation protein (FMRP) with
RT   nucleolin.";
RL   PLoS ONE 9:E91465-E91465(2014).
RN   [15]
RP   INVOLVEMENT IN DEE65, AND VARIANTS DEE65 CYS-87; LEU-87 AND PRO-87.
RX   PubMed=29534297; DOI=10.1002/ana.25208;
RA   Nakashima M., Kato M., Aoto K., Shiina M., Belal H., Mukaida S., Kumada S.,
RA   Sato A., Zerem A., Lerman-Sagie T., Lev D., Leong H.Y., Tsurusaki Y.,
RA   Mizuguchi T., Miyatake S., Miyake N., Ogata K., Saitsu H., Matsumoto N.;
RT   "De novo hotspot variants in CYFIP2 cause early-onset epileptic
RT   encephalopathy.";
RL   Ann. Neurol. 83:794-806(2018).
CC   -!- FUNCTION: Involved in T-cell adhesion and p53/TP53-dependent induction
CC       of apoptosis. Does not bind RNA. As component of the WAVE1 complex,
CC       required for BDNF-NTRK2 endocytic trafficking and signaling from early
CC       endosomes (By similarity). {ECO:0000250|UniProtKB:Q5SQX6,
CC       ECO:0000269|PubMed:10449408, ECO:0000269|PubMed:15048733,
CC       ECO:0000269|PubMed:17245118}.
CC   -!- SUBUNIT: Component of the WAVE1 complex composed of ABI2, CYFIP2, BRK1,
CC       NCKAP1 and WASF1/WAVE1. Interacts with FMR1, FXR1 and FXR2 (By
CC       similarity). Interacts with FMR1 isoform 6; the interaction occurs in a
CC       RNA-dependent manner (PubMed:24658146). Interacts with RAC1 (activated
CC       form) which causes the complex to dissociate, releasing activated WASF1
CC       (PubMed:15048733). The complex can also be activated by NCK1
CC       (PubMed:15048733). Interacts with SHANK3; the interaction mediates the
CC       association of SHANK3 with the WAVE1 complex (By similarity). Interacts
CC       with TMEM108 (via N-terminus); the interaction associates TMEM108 with
CC       the WAVE1 complex (By similarity). {ECO:0000250|UniProtKB:Q5SQX6,
CC       ECO:0000269|PubMed:15048733, ECO:0000269|PubMed:24658146}.
CC   -!- INTERACTION:
CC       Q96F07; Q06787: FMR1; NbExp=2; IntAct=EBI-2433893, EBI-366305;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10449408,
CC       ECO:0000269|PubMed:17245118}. Nucleus {ECO:0000269|PubMed:17245118}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q5SQX6}. Synapse,
CC       synaptosome {ECO:0000250|UniProtKB:Q5SQX6}. Note=Highly expressed in
CC       the perinuclear regionand enriched in synaptosomes (By similarity).
CC       Treatment with leptomycin-B triggers translocation to the nucleus
CC       (PubMed:17245118). {ECO:0000250|UniProtKB:Q5SQX6,
CC       ECO:0000269|PubMed:17245118}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96F07-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:10449408};
CC         IsoId=Q96F07-2; Sequence=VSP_052349;
CC   -!- TISSUE SPECIFICITY: Expressed in T-cells. Increased expression is
CC       observed in CD4(+) T-lymphocytes from patients with multiple sclerosis
CC       (at protein level). {ECO:0000269|PubMed:15048733}.
CC   -!- INDUCTION: By p53/TP53. {ECO:0000269|PubMed:17245118}.
CC   -!- RNA EDITING: Modified_positions=320 {ECO:0000269|PubMed:10574461,
CC       ECO:0000269|PubMed:11230166, ECO:0000269|PubMed:15731336};
CC       Note=Partially edited. Editing appears to be brain-specific.
CC       {ECO:0000269|PubMed:15731336};
CC   -!- DISEASE: Developmental and epileptic encephalopathy 65 (DEE65)
CC       [MIM:618008]: A form of epileptic encephalopathy, a heterogeneous group
CC       of severe early-onset epilepsies characterized by refractory seizures,
CC       neurodevelopmental impairment, and poor prognosis. Development is
CC       normal prior to seizure onset, after which cognitive and motor delays
CC       become apparent. DEE65 is an autosomal dominant form characterized by
CC       onset of intractable seizures usually in the first 6 months of life and
CC       severe to profound psychomotor developmental delay.
CC       {ECO:0000269|PubMed:29534297}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the CYFIP family. {ECO:0000255}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86482.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAD97324.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF160973; AAD45723.1; -; mRNA.
DR   EMBL; AB032994; BAA86482.2; ALT_INIT; mRNA.
DR   EMBL; AL136549; CAB66484.1; -; mRNA.
DR   EMBL; AK223604; BAD97324.1; ALT_INIT; mRNA.
DR   EMBL; AC008676; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61604.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61605.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61606.1; -; Genomic_DNA.
DR   EMBL; BC011762; AAH11762.1; -; mRNA.
DR   CCDS; CCDS75364.1; -. [Q96F07-2]
DR   CCDS; CCDS78077.1; -. [Q96F07-1]
DR   PIR; T46248; T46248.
DR   RefSeq; NP_001032410.1; NM_001037333.2. [Q96F07-2]
DR   RefSeq; NP_001278650.1; NM_001291721.1.
DR   RefSeq; NP_001278651.1; NM_001291722.1. [Q96F07-1]
DR   RefSeq; NP_055191.2; NM_014376.3. [Q96F07-2]
DR   RefSeq; XP_011532818.1; XM_011534516.2. [Q96F07-2]
DR   RefSeq; XP_016864830.1; XM_017009341.1.
DR   AlphaFoldDB; Q96F07; -.
DR   SMR; Q96F07; -.
DR   BioGRID; 117945; 163.
DR   IntAct; Q96F07; 56.
DR   MINT; Q96F07; -.
DR   STRING; 9606.ENSP00000444645; -.
DR   GlyCosmos; Q96F07; 1 site, 1 glycan.
DR   GlyGen; Q96F07; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q96F07; -.
DR   MetOSite; Q96F07; -.
DR   PhosphoSitePlus; Q96F07; -.
DR   SwissPalm; Q96F07; -.
DR   BioMuta; CYFIP2; -.
DR   DMDM; 134034199; -.
DR   EPD; Q96F07; -.
DR   jPOST; Q96F07; -.
DR   MassIVE; Q96F07; -.
DR   MaxQB; Q96F07; -.
DR   PaxDb; Q96F07; -.
DR   PeptideAtlas; Q96F07; -.
DR   ProteomicsDB; 76481; -. [Q96F07-1]
DR   ProteomicsDB; 76482; -. [Q96F07-2]
DR   Antibodypedia; 28408; 169 antibodies from 27 providers.
DR   DNASU; 26999; -.
DR   Ensembl; ENST00000616178.4; ENSP00000479719.1; ENSG00000055163.21. [Q96F07-1]
DR   Ensembl; ENST00000618329.4; ENSP00000484819.1; ENSG00000055163.21. [Q96F07-2]
DR   Ensembl; ENST00000620254.5; ENSP00000479968.1; ENSG00000055163.21. [Q96F07-2]
DR   GeneID; 26999; -.
DR   KEGG; hsa:26999; -.
DR   MANE-Select; ENST00000620254.5; ENSP00000479968.1; NM_001037333.3; NP_001032410.1. [Q96F07-2]
DR   UCSC; uc003lwt.5; human. [Q96F07-1]
DR   AGR; HGNC:13760; -.
DR   CTD; 26999; -.
DR   DisGeNET; 26999; -.
DR   GeneCards; CYFIP2; -.
DR   HGNC; HGNC:13760; CYFIP2.
DR   HPA; ENSG00000055163; Tissue enhanced (brain, kidney).
DR   MalaCards; CYFIP2; -.
DR   MIM; 606323; gene.
DR   MIM; 618008; phenotype.
DR   neXtProt; NX_Q96F07; -.
DR   OpenTargets; ENSG00000055163; -.
DR   Orphanet; 442835; Non-specific early-onset epileptic encephalopathy.
DR   PharmGKB; PA38368; -.
DR   VEuPathDB; HostDB:ENSG00000055163; -.
DR   eggNOG; KOG3534; Eukaryota.
DR   GeneTree; ENSGT00500000044831; -.
DR   HOGENOM; CLU_002688_2_1_1; -.
DR   InParanoid; Q96F07; -.
DR   OMA; DQPNRVE; -.
DR   OrthoDB; 446059at2759; -.
DR   PhylomeDB; Q96F07; -.
DR   PathwayCommons; Q96F07; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9664422; FCGR3A-mediated phagocytosis.
DR   SignaLink; Q96F07; -.
DR   BioGRID-ORCS; 26999; 14 hits in 360 CRISPR screens.
DR   ChiTaRS; CYFIP2; human.
DR   GeneWiki; CYFIP2; -.
DR   GenomeRNAi; 26999; -.
DR   Pharos; Q96F07; Tbio.
DR   PRO; PR:Q96F07; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q96F07; protein.
DR   Bgee; ENSG00000055163; Expressed in renal medulla and 207 other tissues.
DR   ExpressionAtlas; Q96F07; baseline and differential.
DR   Genevisible; Q96F07; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031209; C:SCAR complex; IDA:ARUK-UCL.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0031267; F:small GTPase binding; IEA:InterPro.
DR   GO; GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0000902; P:cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0030031; P:cell projection assembly; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0097484; P:dendrite extension; IEA:Ensembl.
DR   GO; GO:0051388; P:positive regulation of neurotrophin TRK receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro.
DR   InterPro; IPR009828; CYRIA/CYRIB_Rac1-bd.
DR   InterPro; IPR008081; Cytoplasmic_FMR1-int.
DR   PANTHER; PTHR12195:SF3; CYTOPLASMIC FMR1-INTERACTING PROTEIN 2; 1.
DR   PANTHER; PTHR12195; CYTOPLASMIC FMR1-INTERACTING PROTEIN-RELATED; 1.
DR   Pfam; PF07159; CYRIA-B_Rac1-bd; 1.
DR   Pfam; PF05994; FragX_IP; 2.
DR   PIRSF; PIRSF008153; FMR1_interacting; 1.
DR   PRINTS; PR01698; CYTOFMRPINTP.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Apoptosis; Cell adhesion; Cytoplasm;
KW   Disease variant; Epilepsy; Nucleus; Reference proteome; RNA editing;
KW   Synapse; Synaptosome.
FT   CHAIN           1..1278
FT                   /note="Cytoplasmic FMR1-interacting protein 2"
FT                   /id="PRO_0000279709"
FT   MOD_RES         1062
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         558..582
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10449408,
FT                   ECO:0000303|PubMed:11230166, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_052349"
FT   VARIANT         87
FT                   /note="R -> C (in DEE65; dbSNP:rs1131692231)"
FT                   /evidence="ECO:0000269|PubMed:29534297"
FT                   /id="VAR_080817"
FT   VARIANT         87
FT                   /note="R -> L (in DEE65; dbSNP:rs1554108163)"
FT                   /evidence="ECO:0000269|PubMed:29534297"
FT                   /id="VAR_080818"
FT   VARIANT         87
FT                   /note="R -> P (in DEE65; dbSNP:rs1554108163)"
FT                   /evidence="ECO:0000269|PubMed:29534297"
FT                   /id="VAR_080819"
FT   VARIANT         320
FT                   /note="K -> E (in RNA edited version; dbSNP:rs3207362)"
FT                   /evidence="ECO:0000269|PubMed:15731336"
FT                   /id="VAR_030953"
FT   CONFLICT        796
FT                   /note="I -> T (in Ref. 8; AAH11762)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1278 AA;  148399 MW;  D6562B1204DC2463 CRC64;
     MTTHVTLEDA LSNVDLLEEL PLPDQQPCIE PPPSSIMYQA NFDTNFEDRN AFVTGIARYI
     EQATVHSSMN EMLEEGHEYA VMLYTWRSCS RAIPQVKCNE QPNRVEIYEK TVEVLEPEVT
     KLMKFMYFQR KAIERFCSEV KRLCHAERRK DFVSEAYLLT LGKFINMFAV LDELKNMKCS
     VKNDHSAYKR AAQFLRKMAD PQSIQESQNL SMFLANHNRI TQCLHQQLEV IPGYEELLAD
     IVNICVDYYE NKMYLTPSEK HMLLKVMGFG LYLMDGNVSN IYKLDAKKRI NLSKIDKFFK
     QLQVVPLFGD MQIELARYIK TSAHYEENKS KWTCTQSSIS PQYNICEQMV QIRDDHIRFI
     SELARYSNSE VVTGSGLDSQ KSDEEYRELF DLALRGLQLL SKWSAHVMEV YSWKLVHPTD
     KFCNKDCPGT AEEYERATRY NYTSEEKFAF VEVIAMIKGL QVLMGRMESV FNQAIRNTIY
     AALQDFAQVT LREPLRQAVR KKKNVLISVL QAIRKTICDW EGGREPPNDP CLRGEKDPKG
     GFDIKVPRRA VGPSSTQACQ WSPRALFHPT GGTQGRRGCR SLLYMVRTML ESLIADKSGS
     KKTLRSSLDG PIVLAIEDFH KQSFFFTHLL NISEALQQCC DLSQLWFREF FLELTMGRRI
     QFPIEMSMPW ILTDHILETK EPSMMEYVLY PLDLYNDSAY YALTKFKKQF LYDEIEAEVN
     LCFDQFVYKL ADQIFAYYKA MAGSVLLDKR FRAECKNYGV IIPYPPSNRY ETLLKQRHVQ
     LLGRSIDLNR LITQRISAAM YKSLDQAISR FESEDLTSIV ELEWLLEINR LTHRLLCKHM
     TLDSFDAMFR EANHNVSAPY GRITLHVFWE LNFDFLPNYC YNGSTNRFVR TAIPFTQEPQ
     RDKPANVQPY YLYGSKPLNI AYSHIYSSYR NFVGPPHFKT ICRLLGYQGI AVVMEELLKI
     VKSLLQGTIL QYVKTLIEVM PKICRLPRHE YGSPGILEFF HHQLKDIIEY AELKTDVFQS
     LREVGNAILF CLLIEQALSQ EEVCDLLHAA PFQNILPRVY IKEGERLEVR MKRLEAKYAP
     LHLVPLIERL GTPQQIAIAR EGDLLTKERL CCGLSMFEVI LTRIRSYLQD PIWRGPPPTN
     GVMHVDECVE FHRLWSAMQF VYCIPVGTNE FTAEQCFGDG LNWAGCSIIV LLGQQRRFDL
     FDFCYHLLKV QRQDGKDEII KNVPLKKMAD RIRKYQILNN EVFAILNKYM KSVETDSSTV
     EHVRCFQPPI HQSLATTC
//
